Daniel Hochhauser

Daniel Hochhauser is Co-Director of the Cancer Research UK-UCL Centre, Kathleen Ferrier Professor and consultant medical oncologist at University College London.

He has a clinical interest in gastrointestinal oncology. Research areas are in the modulation of DNA interactive agents by novel therapies including inhibition of the epidermal growth factor receptor. Additionally, he has an interest in early phase clinical trials and is currently principal investigator for several novel agents.

After qualifying in medicine from Cambridge and the Royal Free Hospital and postgraduate medical training in London and Oxford, he completed research for a DPhil at the Institute of Molecular Medicine in Oxford. Subsequently he worked as a medical oncology fellow at Memorial Sloan Kettering Cancer Center, New York before appointment as consultant in 1996.